Our analyses of both the human lung samples and LILRB4-deficeint mice suggest that LILRB4, which is upregulated on lung IMs in COPD patients, may have a protective effect against emphysema formation through decreasing MMP-12 expression. The gene discussed is LILRB4; the disease is pulmonary emphysema.